EFC Congress 2026
Preliminary Scientific Programme
The Congress is going to be held in Central European Summer Time zone. To convert to your time zone, please click here.
Pre-Congress Workshop and Course
Wednesday October 14, 2026
Pre-congress courses
ROOM 1
Vulvo-vaginal colposcopy masterclass
08:00 – 13:00 Including skills for vagina/vulval/perianal biopsy and treatment
*Min participants: 25
*Max participants: 75
13:00 – 14:00 Lunch
Challenging colposcopy
14:00 – 19:00 Difficult cases + “Bring Your Own Case”(BYOC) Workshops: Delegates submit difficult cases and a small-group experts review them LIVE
*Min participants: 25
*Max participants: 75
ROOM 2
Training the trainers
08:00 – 13:00
*Min participants: 25
*Max participants: 75
13:00 – 14:00 Lunch
Colposcopy Skills Masterclass
14:00 – 19:00 Video-Based Masterclass
Short “How I do it” procedure videos with discussion
*Min participants: 25
*Max participants: 75
ROOM 3
Cervical Cancer Prevention in Romania: From Screening to Precision Colposcopy
08:00 – 13:00
*Max participants: 50
13:00 – 14:00 Lunch
Hands-on training course (Ablation, TA & Laser, LLETZ)
14:00 – 19:00 6 stations
*Max participants: 50
Congress
From Thursday October 15 to Saturday October 17
Live streaming available
SCREENING AND PREVENTION
08:00 – 08:30 Welcome Session
08:30 – 10:30 1. HPV vaccination in Europe: success, inequality and unintended consequences
- 08:30 – 08:50 EFC statements regarding vaccination after treatment
- 08:50 – 09:10 HPV vaccination in Europe: one continent with different realities
- 09:10 – 09:30 Early adopters’ experience: lessons from highly vaccinated European countries
- 09:30 – 09:50 Cervical Cancer Screening in vaccinated women
- 09:50 – 10:10 HPV Vaccination outside the teenage
- 10:10 – 10:30 Discussion
10:30 – 11:00 Coffe-break
11:00 – 13:00 2. Screening strategies (personalized screening, self-sampling)
From algorithms to clinical practice: can personalized screening be implemented in Europe?
- 11:10 – 11:20 HPV Self-sampling in Europe: where are we now?
- 11:20 – 11:40 HPV vaccination in Europe – One algorithm, many Europes:
can personalised screening be standardised? - 11:40 – 12:00 Screening Failures: why do cancers still occur in screened women?
- 12:00 – 12:20 Molecular markers in screening
- 12:20 – 12:40 Screening in European setting when resources are limited
- 12:40 – 13:00 Discussion
13:00 – 14:00 Lunch
14:00 – 16:00 3. Current knowledge on HPV natural history and microbiome/ HPV Natural History
Revisited: Persistence, Latency and Clinical Consequences
- 14:00 – 14:20 The current model of HPV persistency and CIN development
- 14:20 – 14:40 Persistence vs progression: why most HPV infections do not behave the same
- 14:40 – 15:00 The vaginal microbiome: cause, consequence or confounder?
- 15:00 – 15:20 HPV Reactivation or Redetection in Older Women: A Real Phenomenon?
- 15:20 – 15:40 HPV treatment/ new treatment for microbioma / therapeutic vaccines
- 15:40 – 16:00 Discussion
16:00 – 16:30 Coffe-break
16:30 – 18:00 4. The grand triage challenge:
interactive case voting & discussion
- 16:30 – 16:45 Persistent high-Risk HPV with repeated low-grade cytology
- 16:45 – 17:00 HPV16 positive, cytology negative, type 3 transformation zone
- 17:00 – 17:15 HPV Persistence with negative citology and normal coposcopy
- 17:15 – 17:30 Post-treatment HPV positivity with normal colposcopy
- 17:30 – 17:45 HPV positive woman over 50 with negative cytology
- 17:45 – 18:00 Abnormal cytology but HPV negative
18:00 – 18:45 Oral Presentations (I)
COLPOSCOPY EXCELLENCE DAY
08:00 – 08:45 Oral Presentations (II)
08:45 – 10:40 5. At the cutting edge in colposcopy
- 08:45 – 09:05 Consensus statement on older women
- 09:05 – 09:25 ESGO-EFC consensus on EEC
- 09:25 – 09:45 AI in cervical cancer screening and colposcopy: current evidence in clinical integration in Europe
- 09:45 – 10:05 New technologies in colposcopy
- 10:05 – 10:25 Recent updates in the IFCPC Classification
- 10:25 – 10:40 Discussion
10:40 – 11:00 Coffe-break
11:00 – 13:00 6. Optimal management in cervical intraepithelial neoplasia
- 11:00 – 11:20 EFC consensus CIN2
- 11:20 – 11:40 Optimal management of high grade cervical squamous lesions
- 11:40 – 12:00 CIN2: perspectives and concerns of the pathologist
- 12:00 – 12:20 CIN management and reproductive outcomes: where should we draw the line?
- 12:20 – 12:40 Ablation or excision: how to choose the optimal treatment
- 12:40 – 13:00 Discussion
13:00 – 14:00 Lunch
14:00 – 16:00 7. Quality Assurance in Europe: standards, gaps and real-life challenges
- 14:00 – 14:20 Key quality indicators: detection rates, biopsies, margins, follow-up
- 14:20 – 14:40 EFC practical QA toolkit for daily practice in colposcopy
- 14:40 – 15:00 Strengthening Colposcopy Quality within EUCanScreen
- 15:00 – 15:20 Implementing QA in the transitional setting in Europe
- 15:20 – 15:40 How to solve a quality improvement problem?
- 15:40 – 16:00 Discussion
16:00 – 16:30 Coffe-break
16:30 – 18:00 8. Challenging Clinical cases – Mock MDT (Multidisciplinary Team)
- 16:30 – 16:45 Cervical Congenital metaplasia with abnormal citology/HPV positive test
- 16:45 – 17:00 HSIL (CIN 2/3) on histology in adolescence
- 17:00 – 17:15 CIN 2/3 in an HIV-Positive (imunocompromised) patient
- 17:15 – 17:30 Glandular lesion of the cervix
- 17:30 – 17:45 Persistent HPV Infection and VAIN in a Patient after Hysterectomy
- 17:45 – 18:00 Discordant results: persistent HPV, abnormal cytology, negative biopsies
18:00 – 18:45 Oral Presentations (III)
PATIENT-CENTRED CARE & REPRODUCTIVE OUTCOMES
08:00 – 08:45 Oral Presentations (IV)
08:45 – 10:40 9. Patient information, medico-legal aspects, social media, patient trauma informed
- 08:45 – 09:05 Trauma-informed colposcopy: why it matters more than we think
- 09:05 – 09:25 Informed consent in colposcopy: are we really protected?
- 09:25 – 09:45 Communicating HPV Results without Inducing Fear: Counselling Strategies for HPV-positive patients
- 09:45 – 10:05 When things go wrong: complaints, litigation and learning from adverse events
- 10:05 – 10:25 Social media, misinformation and HPV: who shapes the patient narrative?
- 10:24 – 10:40 Discussion
10:40 – 11:00 Coffe-break
11:00 – 12:45 10. Shared difficult decisions: Supporting Fertility-Sensitive Care
- 11:00 – 11:20 HPV infection during pregnancy: how to counsel our patients
- 11:20 – 11:40 Clinical Management of Positive Margins after LLETZ
- 11:40 – 12:00 Adenocarcinoma in Situ of the Cervix in a Woman Desiring Future Fertility
- 12:00 – 12:20 Colposcopy in Pregnancy: Benign Mimickers of Cervical Neoplasia
12:30 – 13:00 Closing ceremony
Tickets
Register for EFC Congress 2026
11th European Federation For Colposcopy Congress
“Cervical cancer prevention and colposcopy”
Get In Touch
Contact us if you require more information or have any question.